{"authors": [["Jiang", "L", "L", "Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China."], ["Song", "Y", "Y", null], ["Xu", "J J", "JJ", null], ["Tang", "X F", "XF", null], ["Wang", "H H", "HH", null], ["Jiang", "P", "P", null], ["Gao", "L J", "LJ", null], ["Song", "L", "L", null], ["Gao", "Z", "Z", null], ["Chen", "J", "J", null], ["Gao", "R L", "RL", null], ["Qiao", "S B", "SB", null], ["Yang", "Y J", "YJ", null], ["Xu", "B", "B", null], ["Yuan", "J Q", "JQ", null]], "date": null, "id": "29325366", "text": "Objective: To investigate the in-hospital and long-term outcomes of patients with left ventricular ejection fraction (LVEF) <50% undergoing percutaneous coronary intervention (PCI) . Methods: From January to December 2013, 10 445 consecutive patients who underwent PCI in Fuwai Hospital and the LVEF value was available were prospectively included. The patients were divided into LVEF\u226550% group (9 896 cases) and LVEF<50% group (549 cases) . The in-hospital and 2-year clinical outcomes were compared between the 2 groups. The association between LVEF<50% and clinical outcomes was assessed using multivariable Cox regression analysis. Results: (1) Compared with LVEF \u226550% group, LVEF< 50% group had higher rates of in-hospital all-cause death (1.1% (6/549) vs. 0.2% (17/9 896) , P<0.01) , cardiac death (1.1% (6/549) vs. 0.1% (12/9 896) , P<0.01) , in-stent thrombosis (0.7% (4/549) vs. 0.2% (18/9 896) , P<0.01) , myocardial infarction (2.4% (13/549) vs. 1.2% (121/9 896) , P<0.05) ,and major adverse cardiovascular and cerebrovascular events (MACCE) which including death, myocardial infarction, revascularization, in-stent thrombosis, and stroke (3.6% (20/549) vs. 1.4% (137/9 896) , P<0.01) . (2) A total of 10 388 (99.5%) patients completed 2-year follow-up. Compared with LVEF \u226550% group, LVEF<50% group had higher rates of 2-year all-cause death (4.7% (26/549) vs. 1.0% (101/9 896) , P<0.01) , cardiac death (4.0% (22/549) vs. 0.5% (50/9 896) , P<0.01) , in-stent thrombosis (3.1% (17/549) vs. 0.7% (71/9 896) , P<0.001) , myocardial infarction (4.2% (23/549) vs. 1.9% (186/9 896) , P<0.01) ,and MACCE (17.9% (98/549) vs. 11.8% (1 172/9 896) , P<0.01) . There were no significant differences on the rates of 2-year target-vessel revascularization, bleeding and stroke between the two groups. (3) The multivariable Cox regression analysis demonstrated that LVEF< 50% was the independent risk factor of 2-year all-cause death (HR=2.47, 95%CI 1.49-4.08, P<0.01) , cardiac death (HR=3.25, 95%CI 1.79-5.90, P<0.01) , in-stent thrombosis (HR=4.19, 95%CI 2.39-7.34, P<0.01) , myocardial infarction (HR=2.00, 95%CI 1.26-3.16, P<0.01) , and MACCE (HR=1.40, 95%CI 1.13-1.74, P<0.01) . (4) After propensity score matching, all in-hospital outcomes were similar between the two groups, including all-cause death, cardiac death, in-stent thrombosis, myocardial infarction, revascularization, bleeding, stroke, and MACCE (all P>0.05) . After propensity score matching,the multivariable Cox regression analysis demonstrated that LVEF<50% was still an independent risk factor of 2-year all-cause death (HR=3.08, 95%CI 1.37-6.89, P<0.01) , cardiac death (HR= 4.12, 95%CI 1.53-11.07, P<0.01) ,and in-stent thrombosis (HR=3.82, 95%CI 1.27-11.5, P<0.05) . Conclusion: LVEF< 50% is an independent risk factor of 2-year all-cause death, cardiac death, and in-stent thrombosis in patients undergoing PCI, but it does not increase the risk of target-vessel revascularization, bleeding or stroke.\u76ee\u7684\uff1a \u63a2\u8ba8\u5de6\u5fc3\u5ba4\u5c04\u8840\u5206\u6570\uff08LVEF\uff09<50%\u7684\u51a0\u5fc3\u75c5\u60a3\u8005\u7ecf\u76ae\u51a0\u72b6\u52a8\u8109\u4ecb\u5165\u6cbb\u7597\uff08PCI\uff09\u672f\u540e\u7684\u9662\u5185\u53ca\u8fdc\u671f\u9884\u540e\u3002 \u65b9\u6cd5\uff1a \u91c7\u7528\u524d\u77bb\u6027\u7814\u7a76\u65b9\u6cd5\uff0c\u8fde\u7eed\u5165\u90092013\u5e741\u81f312\u6708\u5728\u961c\u5916\u533b\u9662\u884cPCI\u4e14\u6709\u8d85\u58f0\u5fc3\u52a8\u56feLVEF\u8d44\u6599\u7684\u51a0\u5fc3\u75c5\u60a3\u800510 445\u4f8b\u3002\u6309\u7167LVEF\u503c\uff0c\u5c06\u5165\u9009\u60a3\u8005\u5206\u4e3aLVEF\u226550%\u7ec4\uff089 896\u4f8b\uff09\u548cLVEF<50%\u7ec4\uff08549\u4f8b\uff09\u3002\u6bd4\u8f832\u7ec4\u60a3\u8005PCI\u672f\u540e\u9662\u5185\u53ca2\u5e74\u4e34\u5e8a\u9884\u540e\uff0c\u5e76\u91c7\u7528\u591a\u56e0\u7d20Cox\u56de\u5f52\u5206\u6790LVEF<50%\u4e0ePCI\u672f\u540e\u4e0d\u826f\u4e8b\u4ef6\u7684\u76f8\u5173\u6027\u3002 \u7ed3\u679c\uff1a \uff081\uff09LVEF<50%\u7ec4\u672f\u540e\u9662\u5185\u5168\u56e0\u6b7b\u4ea1[1.1%\uff086/549\uff09\u6bd40.2%\uff0817/9 896\uff09\uff0cP<0.01]\u3001\u5fc3\u539f\u6027\u6b7b\u4ea1[1.1%\uff086/549\uff09\u6bd40.1%\uff0812/9 896\uff09\uff0cP<0.01]\u3001\u652f\u67b6\u5185\u8840\u6813\u5f62\u6210[0.7%\uff084/549\uff09\u6bd40.2%\uff0818/9 896\uff09, P<0.01]\u3001\u5fc3\u808c\u6897\u6b7b[2.4%\uff0813/549\uff09\u6bd41.2%\uff08121/9 896\uff09, P<0.05]\u548c\u4e3b\u8981\u4e0d\u826f\u5fc3\u8111\u8840\u7ba1\u4e8b\u4ef6[\u5305\u62ec\u6b7b\u4ea1\u3001\u5fc3\u808c\u6897\u6b7b\u3001\u8840\u8fd0\u91cd\u5efa\u3001\u652f\u67b6\u5185\u8840\u6813\u5f62\u6210\u548c\u5352\u4e2d\uff0c3.6%\uff0820/549\uff09\u6bd41.4%\uff08137/9 896\uff09, P<0.01]\u53d1\u751f\u7387\u5747\u9ad8\u4e8eLVEF\u226550%\u7ec4\u3002\uff082\uff0910 388\u4f8b\uff0899.5%\uff09\u60a3\u8005\u5b8c\u6210PCI\u672f\u540e2\u5e74\u968f\u8bbf\u3002LVEF<50%\u7ec4\u672f\u540e2\u5e74\u5168\u56e0\u6b7b\u4ea1[4.7%\uff0826/549\uff09\u6bd41.0%\uff08101/9 896\uff09, P<0.01]\u3001\u5fc3\u539f\u6027\u6b7b\u4ea1[4.0%\uff0822/549\uff09\u6bd40.5%\uff0850/9 896\uff09, P<0.01]\u3001\u652f\u67b6\u5185\u8840\u6813\u5f62\u6210[3.1%\uff0817/549\uff09\u6bd40.7%\uff0871/9 896\uff09, P<0.01]\u3001\u5fc3\u808c\u6897\u6b7b[4.2%\uff0823/549\uff09\u6bd41.9%\uff08186/9 896\uff09, P<0.01]\u548c\u4e3b\u8981\u4e0d\u826f\u5fc3\u8111\u8840\u7ba1\u4e8b\u4ef6[17.9%\uff0898/549\uff09\u6bd411.8%\uff081172/9 896\uff09, P<0.01]\u53d1\u751f\u7387\u5747\u9ad8\u4e8eLVEF\u226550%\u7ec4\uff0c\u800c\u4e24\u7ec4\u4e4b\u95f4\u7684\u9776\u8840\u7ba1\u91cd\u5efa\u3001\u51fa\u8840\u548c\u5352\u4e2d\u53d1\u751f\u7387\u5dee\u5f02\u5747\u65e0\u7edf\u8ba1\u5b66\u610f\u4e49\uff08P\u5747>0.05\uff09\u3002\uff083\uff09\u591a\u56e0\u7d20Cox\u56de\u5f52\u5206\u6790\u663e\u793a\uff0cLVEF<50%\u662fPCI\u672f\u540e2\u5e74\u5168\u56e0\u6b7b\u4ea1\uff08HR=2.47\uff0c95%CI 1.49~4.08\uff0cP<0.01\uff09\u3001\u5fc3\u539f\u6027\u6b7b\u4ea1\uff08HR=3.25\uff0c95%CI 1.79~5.90\uff0cP<0.01\uff09\u3001\u652f\u67b6\u5185\u8840\u6813\u5f62\u6210\uff08HR=4.19\uff0c95%CI 2.39~7.34\uff0cP<0.01\uff09\u3001\u5fc3\u808c\u6897\u6b7b\uff08HR=2.00\uff0c95%CI 1.26~3.16\uff0cP<0.01\uff09\u548c\u4e3b\u8981\u4e0d\u826f\u5fc3\u8111\u8840\u7ba1\u4e8b\u4ef6\uff08HR=1.40\uff0c95%CI 1.13~1.74\uff0cP<0.01\uff09\u7684\u72ec\u7acb\u5371\u9669\u56e0\u7d20\u3002\uff084\uff09\u503e\u5411\u6027\u8bc4\u5206\u5339\u914d\u540e\uff0c\u4e24\u7ec4\u4e4b\u95f4\u7684\u672f\u540e\u9662\u5185\u5168\u56e0\u6b7b\u4ea1\u3001\u5fc3\u539f\u6027\u6b7b\u4ea1\u3001\u652f\u67b6\u5185\u8840\u6813\u5f62\u6210\u3001\u5fc3\u808c\u6897\u6b7b\u3001\u518d\u6b21\u8840\u8fd0\u91cd\u5efa\u3001\u51fa\u8840\u3001\u5352\u4e2d\u548c\u4e3b\u8981\u4e0d\u826f\u5fc3\u8111\u8840\u7ba1\u4e8b\u4ef6\u53d1\u751f\u7387\u5dee\u5f02\u5747\u65e0\u7edf\u8ba1\u5b66\u610f\u4e49\uff08P\u5747>0.05\uff09\u3002\u591a\u56e0\u7d20Cox\u56de\u5f52\u5206\u6790\u663e\u793a\uff0c\u503e\u5411\u6027\u8bc4\u5206\u5339\u914d\u540e\uff0cLVEF<50%\u662fPCI\u672f\u540e2\u5e74\u5168\u56e0\u6b7b\u4ea1\uff08HR=3.08\uff0c95%CI 1.37~6.89\uff0cP<0.01\uff09\u3001\u5fc3\u539f\u6027\u6b7b\u4ea1\uff08HR= 4.12, 95%CI 1.53~11.07, P<0.01\uff09\u548c\u652f\u67b6\u5185\u8840\u6813\u5f62\u6210\uff08HR=3.82\uff0c95%CI 1.27~11.5\uff0cP<0.05\uff09\u7684\u72ec\u7acb\u5371\u9669\u56e0\u7d20\u3002 \u7ed3\u8bba\uff1a LVEF<50%\u662f\u51a0\u5fc3\u75c5\u60a3\u8005PCI\u672f\u540e2\u5e74\u5168\u56e0\u6b7b\u4ea1\u3001\u5fc3\u539f\u6027\u6b7b\u4ea1\u53ca\u652f\u67b6\u5185\u8840\u6813\u5f62\u6210\u7684\u72ec\u7acb\u5371\u9669\u56e0\u7d20\uff0c\u4f46\u4e0d\u589e\u52a0\u9776\u8840\u7ba1\u91cd\u5efa\u3001\u51fa\u8840\u53ca\u5352\u4e2d\u7684\u98ce\u9669\u3002.", "doi": null, "title": "[Outcome of patients with coronary artery disease and left ventricular ejection fraction less than 50% undergoing percutaneous coronary intervention].", "journal": ["Zhonghua xin xue guan bing za zhi", "Zhonghua Xin Xue Guan Bing Za Zhi"]}